Literature DB >> 23620229

Modelling the regulation of telomere length: the effects of telomerase and G-quadruplex stabilising drugs.

Bartholomäus V Hirt1, Jonathan A D Wattis, Simon P Preston.   

Abstract

Telomeres are guanine-rich sequences at the end of chromosomes which shorten during each replication event and trigger cell cycle arrest and/or controlled death (apoptosis) when reaching a threshold length. The enzyme telomerase replenishes the ends of telomeres and thus prolongs the life span of cells, but also causes cellular immortalisation in human cancer. G-quadruplex (G4) stabilising drugs are a potential anticancer treatment which work by changing the molecular structure of telomeres to inhibit the activity of telomerase. We investigate the dynamics of telomere length in different conformational states, namely t-loops, G-quadruplex structures and those being elongated by telomerase. By formulating deterministic differential equation models we study the effects of various levels of both telomerase and concentrations of a G4-stabilising drug on the distribution of telomere lengths, and analyse how these effects evolve over large numbers of cell generations. As well as calculating numerical solutions, we use quasicontinuum methods to approximate the behaviour of the system over time, and predict the shape of the telomere length distribution. We find those telomerase and G4-concentrations where telomere length maintenance is successfully regulated. Excessively high levels of telomerase lead to continuous telomere lengthening, whereas large concentrations of the drug lead to progressive telomere erosion. Furthermore, our models predict a positively skewed distribution of telomere lengths, that is, telomeres accumulate over lengths shorter than the mean telomere length at equilibrium. Our model results for telomere length distributions of telomerase-positive cells in drug-free assays are in good agreement with the limited amount of experimental data available.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23620229      PMCID: PMC3975128          DOI: 10.1007/s00285-013-0678-2

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  79 in total

Review 1.  Sizing the ends: normal length of human telomeres.

Authors:  Oumar Samassekou; Macoura Gadji; Régen Drouin; Ju Yan
Journal:  Ann Anat       Date:  2010-08-06       Impact factor: 2.698

2.  Inhibition of telomerase by G-quartet DNA structures.

Authors:  A M Zahler; J R Williamson; T R Cech; D M Prescott
Journal:  Nature       Date:  1991-04-25       Impact factor: 49.962

3.  High-throughput telomere length quantification by FISH and its application to human population studies.

Authors:  Andrés Canela; Elsa Vera; Peter Klatt; María A Blasco
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

4.  Mechanism of acridine-based telomerase inhibition and telomere shortening.

Authors:  Mekala Gunaratnam; Olga Greciano; Cristina Martins; Anthony P Reszka; Christoph M Schultes; Hamid Morjani; Jean-Francois Riou; Stephen Neidle
Journal:  Biochem Pharmacol       Date:  2007-06-16       Impact factor: 5.858

Review 5.  A hitchhiker's guide to G-quadruplex ligands.

Authors:  David Monchaud; Marie-Paule Teulade-Fichou
Journal:  Org Biomol Chem       Date:  2007-11-14       Impact factor: 3.876

6.  SysBioMed report: advancing systems biology for medical applications.

Authors:  O Wolkenhauer; D Fell; P De Meyts; N Blüthgen; H Herzel; N Le Novère; T Höfer; K Schürrle; I van Leeuwen
Journal:  IET Syst Biol       Date:  2009-05       Impact factor: 1.615

7.  Telomeric armor: the layers of end protection.

Authors:  Liana Oganesian; Jan Karlseder
Journal:  J Cell Sci       Date:  2009-11-15       Impact factor: 5.285

8.  Telomerase activity in human germline and embryonic tissues and cells.

Authors:  W E Wright; M A Piatyszek; W E Rainey; W Byrd; J W Shay
Journal:  Dev Genet       Date:  1996

Review 9.  Alternative lengthening of telomeres: models, mechanisms and implications.

Authors:  Anthony J Cesare; Roger R Reddel
Journal:  Nat Rev Genet       Date:  2010-03-30       Impact factor: 53.242

10.  The POT1-TPP1 telomere complex is a telomerase processivity factor.

Authors:  Feng Wang; Elaine R Podell; Arthur J Zaug; Yuting Yang; Paul Baciu; Thomas R Cech; Ming Lei
Journal:  Nature       Date:  2007-01-21       Impact factor: 69.504

View more
  3 in total

Review 1.  Evaluating biomarkers to model cancer risk post cosmic ray exposure.

Authors:  Deepa M Sridharan; Aroumougame Asaithamby; Steve R Blattnig; Sylvain V Costes; Paul W Doetsch; William S Dynan; Philip Hahnfeldt; Lynn Hlatky; Yared Kidane; Amy Kronenberg; Mamta D Naidu; Leif E Peterson; Ianik Plante; Artem L Ponomarev; Janapriya Saha; Antoine M Snijders; Kalayarasan Srinivasan; Jonathan Tang; Erica Werner; Janice M Pluth
Journal:  Life Sci Space Res (Amst)       Date:  2016-05-21

2.  Mathematical modelling of telomere length dynamics.

Authors:  Jonathan A D Wattis; Qi Qi; Helen M Byrne
Journal:  J Math Biol       Date:  2019-11-14       Impact factor: 2.259

3.  Stochastic simulations of normal aging and Werner's syndrome.

Authors:  Qi Qi; Jonathan A D Wattis; Helen M Byrne
Journal:  Bull Math Biol       Date:  2014-04-26       Impact factor: 1.758

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.